Fetal and neonatal outcome and prevention of group B streptococcus intrauterine infection

doi:10.3877/cma.j.issn.2095-3259.2017.04.006

Abstract

Abstract:

Group B streptococcus (GBS) is a type of gram-positive streptococcal bacteria, which can cause multiple adverse pregnancy outcome, including intrauterine infection, stillbirth, neonatal infection and neonatal death. This article will review the prognosis and prevention of fetal and neonatal infection.

Key words: Streptococcus, Pregnancy complications, infectious, Prognosis

Malie Wang, Yanmin Luo. Fetal and neonatal outcome and prevention of group B streptococcus intrauterine infection[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2017, 06(04): 216-218.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2017.04.006

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2017/V06/I04/216

References 17

[1]	Barcaite E, Bartusevicius A, Tameliene R, et al. Prevalence of maternal group B streptococcal colonisation in European countries[J]. Acta Obstet Gynecol Scand, 2008, 87(3):260-271.
[2]	Lu B, Li D, Cui Y, et al. Epidemiology of group B streptococcus isolated from pregnant women in Beijing, China[J]. Clin Microbiol Infect, 2014, 20(6):370-373.
[3]	Verani JR, Mcgee L, Schrag SJ. Prevention of perinatal group B streptococcal disease revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59(11):1-36.
[4]	曹泽毅. 中华妇产科学 [M]. 2版. 北京：人民卫生出版社，2004: 379.
[5]	孙瑜，陈倩，边旭明，等. 北京市七家三级甲等医院宫内感染病例分析[J]. 中华围产医学杂志，2009, 12(5):342-345.
[6]	Kalin A, Acosta C, J Kurinczuk J, et al. Severe sepsis in women with group B streptococcus in pregnancy: an exploratory UK national case-control study[J]. BMJ Open, 2015, 5(12):007976.
[7]	Jahromi BN, Poorarian S, Poorbarfehee S. The prevalence and adverse effects of group B streptococcal colonization during pregnancy[J]. Arch Iranian Med, 2008, 11(6):654-657.
[8]	Cousens S, Blencowe H, Stanton C, et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis[J]. Lancet, 2011, 377:1319-1330.
[9]	Nan C, Dangor Z, Cutland CL, et al. Maternal group B streptococcus-related stillbirth: a systematic review[J]. BJOG, 2015, 122(7):1437-1445.
[10]	Doare KL, Heath PT. An overview of global GBS epidemiology[J]. Vaccine, 2013, 31 Suppl 4:7-12.
[11]	Al-Kadri HM, Bamuhair SS, Al Johani SM, et al. Maternal and neonatal risk factors for early-onset group B streptococcal disease: a case control study[J]. Int J Womens Health, 2013, 5(10):729-735.
[12]	Ahmadzia HK, Heine RP. Diagnosis and management of group B streptococcus in pregnancy[J]. Obstet Gynecol Clin N Am, 2014, 41(8):629-647.
[13]	HW Yu, HC Lin, PH Yang, et al. Group B streptococcal infection in Taiwan: maternal colonization and neonatal infection[J]. Pediatr Neonatol, 2011, 52(8):190-195.
[14]	Håkansson S, Källén K. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997－2001[J]. BJOG, 2006, 113(10):1452-1458.
[15]	Matsubara K, Hoshina K, Suzuki Y. Early-onset and late-onset group B streptococcal disease in Japan: a nationwide surveillance study, 2004－2010[J]. Int J Infect Dis, 2013, 17(11):379-384.
[16]	Money D, Allen VM, Society of Obstetrician and Gynaecologists of Canada. The prevention of early-onset neonatal group B streptococcal disease[J]. J Obstet Gynaecol Can, 2013, 35(10):939-951.
[17]	Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis[J]. N Engl J Med, 2000, 342(1):15-20.

Please choose a citation manager

Content to export